Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus PSN Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction ELTK Q1 2026 Earnings Negative EPS Amid Quiet Quarter Stock Rises 608 Ready Capital Q1 2026 Earnings Massive EPS Miss Highlights Credit Deterioration NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 Almonty Industries ALM Q1 2026 Earnings Widening Loss Surprises Markets Yet Shares Rise